Monday, September 09, 2019 12:17:12 AM
Hmmmm...remember alphapuppy’s post about a middle-age man he saw and met at June’s ASCO, and had a small talk... not an oncologist and is from Philadelphia could it be Michael McNally? Who is Merck’s President of Global Vaccines and his Linkedln shows Greater Philadelphia area.
http://www.pharmexec.com/michael-nally
Michael Nally, President, Global Vaccines, Merck & Co. (known as MSD outside the US & Canada).
Here is alphapuppy’s post on June 2019.
“Yes I agree. I think you might be onto something.
Where I was sitting, I noticed an executive appearing middle aged man who had 3 or 4 young personal assistants with him come in and sit in the front row.
Once he sat down, before the talk, he immediately got up when he saw Linda and it was fairly obvious that they knew each other and he went over and briefly talked with her and shook her hand.
Since he was sitting close to me I asked him where he practiced because I initially thought he might be an oncologist. He said that he worked in Philadelphia.
Tonight after reading your post, I did a Google search and interestingly there quite a few Big Pharma in Philadelphia including Merck and Glaxo And Johnson and Johnson among others.
Also I noticed that he took a photo of every single slide that was presented. And his assistants were actively taking notes.
After the talk he spoke with Dr. Bosch so I assume that he had a research type background possibly.
Just my observations and speculations.”
....well maybe alphapuppy can confirm, the pharma exec link has a picture of him and does look like a middle age man :)
http://www.pharmexec.com/michael-nally
Michael Nally, President, Global Vaccines, Merck & Co. (known as MSD outside the US & Canada).
Here is alphapuppy’s post on June 2019.
“Yes I agree. I think you might be onto something.
Where I was sitting, I noticed an executive appearing middle aged man who had 3 or 4 young personal assistants with him come in and sit in the front row.
Once he sat down, before the talk, he immediately got up when he saw Linda and it was fairly obvious that they knew each other and he went over and briefly talked with her and shook her hand.
Since he was sitting close to me I asked him where he practiced because I initially thought he might be an oncologist. He said that he worked in Philadelphia.
Tonight after reading your post, I did a Google search and interestingly there quite a few Big Pharma in Philadelphia including Merck and Glaxo And Johnson and Johnson among others.
Also I noticed that he took a photo of every single slide that was presented. And his assistants were actively taking notes.
After the talk he spoke with Dr. Bosch so I assume that he had a research type background possibly.
Just my observations and speculations.”
....well maybe alphapuppy can confirm, the pharma exec link has a picture of him and does look like a middle age man :)
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
